irinotecan has been researched along with Tuberous Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuta, T; Hamaya, Y; Ishida, N; Iwaizumi, M; Miura, K; Miyazu, T; Osawa, S; Shinmura, K; Sugimoto, K; Sugimura, H; Suzuki, S; Tamura, S; Tani, S; Yamade, M | 1 |
1 other study(ies) available for irinotecan and Tuberous Sclerosis
| Article | Year |
|---|---|
Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
Topics: Carcinoma, Neuroendocrine; Esophagogastric Junction; Female; Humans; Infant, Newborn; Irinotecan; Middle Aged; Stomach Neoplasms; Tuberous Sclerosis | 2020 |